Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Expands Licensing Agreement With Genencor

NEW YORK, Jan. 21 (GenomeWeb News) - Freemont, Calif.-based Ciphergen Biosystems today announced the expansion of its existing license agreement with Genencor International.

 

Under the expanded terms of the agreement, Ciphergen said it now has exclusive, worldwide right to use Genencor's Hydrophobic Charge Induction chromatography technology for the production of its MEP HyperCel-brand chromatographic sorbents as well as MEP membranes, both of which are used in the capture, purification, and production of monoclonal antibodies. Ciphergen has the right to both distribute products based on this technology through its own channels and third parties. The agreement also conditionally allows Ciphergen to sub-contract MEP Hypercel manufacturing rights under the license to third parties.

 

Financial details were not disclosed.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.